Pneumococcal disease in HIV-infected patients;Infections a pneumocoque chez le patient infecte par le VIH

Presse Medicale

Volumn 26, Issue 5, 1997, Pages 243-247

  Lesprit, Ph ^a   Decazes, J M ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CEFOTAXIME; CEFTRIAXONE; CLAVULANIC ACID; PENICILLIN G; PNEUMOCOCCUS VACCINE; ANTIINFECTIVE AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC RESISTANCE; CLINICAL FEATURE; DISEASE COURSE; DRUG EFFICACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATHOPHYSIOLOGY; PNEUMONIA; PROGNOSIS; REVIEW; STREPTOCOCCUS PNEUMONIAE; VACCINATION; AIDS RELATED COMPLEX; DRUG COMBINATION; LOBAR PNEUMONIA; TIME;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-BACTERIAL AGENTS; DRUG THERAPY, COMBINATION; HIV INFECTIONS; HUMANS; PNEUMONIA, PNEUMOCOCCAL; PROGNOSIS; TIME FACTORS;

EID: 0030935789     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Polsky B, Gold JWM, Whimbey E et al. Bacterial pneumonia in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1986; 104:38-41.
2. Redd SC, Rutherford GW 3d, Sande MA et al. The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents. J Infect Dis 1990 ; 162:1012-7.
3. Gilks CF, Ojoo SA, Ojoo JC et al. Invasive pneumococcal disease in a cohort of predominantly HIV-1 infected female sex-workers in Nairobi, Kenya. Lancet 1996 ; 347:718-23.
4. Janoff EN, Breiman RF, Daley CF et al. Pneumococcal disease during HIV infection. Epidemiologic, clinical and immunologic perspectives. Ann Intern Med 1992 ; 117:314-24.
5. Selwyn PA, Feingold AR, Hartel D et al. Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDS. AIDS 1988 ; 2:267-72.
6. Mao C, Harper M, McIntosh K et al. Invasive pneumococcal infections in human immunodeficiency virus-infected children. J Infect Dis 1996 ; 173:870-6.
7. Gebo KA, Moore RD, Keruly JC, Chaisson RE. Risk factors for pneumococcal disease in human immunodeficiency virus-infected patients. J Infect Dis 1996 ; 173:857-62.
8. Pesola GR, Charles A. Pneumococcal bacteremia with pneumonia. Mortality in acquired immunodeficiency syndrome. Chest 1992 ; 101:150-5.
9. Rodriguez Barradas MC, Musher DM, Hamil RJ et al. Unusual manifestations of pneumococcal infection in human immunodeficiency virus-infected individuals: the past revisited. Clin Infect Dis 1992 ; 14:192-9.
10. Hirschtick RE, Glassroth J, Jordan MC et al. Bacterial pneumonia in persons infected with the human immunodeficiency virus. N Engl J Med 1995 ; 333:845-51.
11. Duval X, Paty MC, Longuet P et al. Pneumopathies dues à Streptococcus pneumoniae chez 27 malades infectés par le VIH. Presse Med 1995 ; 24:715-8.
12. Janoff EN, O'Brien J, Duval G et al. Bacteremia, pharyngeal colonization and immune response to Streptococcus pneumoniae in persons with HIV (Abstract). The 31st Annuel Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Illinois, 1991.
13. Witt DJ, Craven DE, McCabe WR. Bacterial infections in adult patients with the acquired immune deficiency syndrome (AIDS) and AIDS-related complex. Am J Med 1987 ; 82:900-6.
14. Torri O, Mariel C, Veyssier P et al. Bactériémies à Streptococcus pneumoniae et infection par le VIH. Étude rétrospective de 41 épisodes chez 30 malades. Presse Med 1994 ; 23:972-5.
15. Bédos JP, Chastang C, Geslin P, Régnier B. Résultats de l'enquête nationale sur la résistance du pneumocoque : épidémiologie descriptive et facteurs de risque. In: Infections à pneumocoque de sensibilité diminuée aux bêta-lactamines, Carbon C, Chastang C, Decazes JM eds. Springer Verlag, Paris 1993 :89-98.
16. Bédos JP, Chevret S, Chastang C et al. Epidemiological features of and risk factors for infection by Streptococcus pneumoniae strains with diminished susceptibility to penicillin: findings of a french survey. Clin Infect Dis 1996 ; 22:63-72.
17. Garcia-Leoni ME, Cercenado E, Rodeno P et al. Susceptibility of Streptococcus pneumoniae to penicillin: a prospective microbiological and clinical study. Clin Infect Dis 1992 ; 14:427-35.
18. Nava JM, Bella F, Garau J et al. Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study. Clin Infect Dis 1994 ; 19:884-90.
19. Pallares R, Gudiol F, Linares J et al. Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci. N Engl J Med 1987 ; 317:1-22.
20. Comité de l'Antibiogramme de la Société Française de Microbiologie. Pathol Biol 1994 ; 42:I-VIII.
21. Blumberg HM, Rimland D. Nosocomial infection with penicillin-resistant pneumococci in patients with AIDS. J Infect Dis 1989 ; 160:725-6.
22. Gellert G, Bock BV, Meyers H et al. Penicillin-resistant pneumococcal meningitis in an HIV-infected man. N Engl J Med 1991 ; 325:1047-8.
23. Léophonte P, Mularczyk M, Rouquet RM, Geslin P et les membres du Groupe de Réflexion sur l'Infection en Pneumologie (GRIP). Résultats d'une enquête nationale sur les pneumonies à pneumocoque hospitalisées (210 cas). In: Infections à pneumocoque de sensibilité diminuée aux bêta-lactamines, Carbon C, Chastang C, Decazes JM eds. Springer Verlag, Pans 1993 :39-108.
24. Bédos JP, Vallée E, Moine P et al. Pneumonies à S. pneumoniae de sensibilité diminuée à la pénicilline : données épidémiologiques, facteurs de risque et impact thérapeutique. Med Mal Infect 1995 ; 25:1-8.
25. Meynard JL, Barbut F, Blum L et al. Risk factors for isolation of Streptococcus pneumoniae with decreased susceptibility to penicillin G from patients infected with human immunodeficiency virus. Clin Infect Dis 1996 ; 22:437-40.
26. Rodriguez-Barradas M, Lache C, Grover J et al. Streptococcus pneumoniae colonization among HIV-infected subjects: impact of immunization, CD4 count and trimethoprim-sulfamethoxazole prophylaxis (Abstract). 34th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, Florida, 1994.
27. Burack JH, Hahn JA, Saint-Maurice D et al. Microbiology of community-acquired bacterial pneumonia in persons with and at risk for human immunodeficiency virus type 1 infection. Arch Intern Med 1994 ; 154:2589-96.
28. Friedland IR, McCracken GH. Management of infections caused by antibiotic-resistant Streptococcus pneumonioe. N Engl J Med 1994 ; 331:377-82.
29. Defouilloy C, Fremaux A, Mehdaoui A et al. La résistance de Streptococcus pneumoniae à la pénicilline. Résistance « bactériologique »/résistance « clinique ». Pathol Biol 1994 ; 42:475-80.
30. Rose DN, Schechter CB, Sacks HS. Influenza and pneumococcal vaccination of HIV-infected patients: a policy analysis. Am J Med 1993 ; 94:160-8.
31. Simberkoff MS, El Sadr W, Schiffman G, Rahal JJ. Streptococcus pneumoniae infections and bacteremia in patients with acquired immune deficiency syndrome, with report of a pneumococcal vaccine failure. Am Rev Respir Dis 1984 ; 130:1174-6.
32. Rodriguez-Barradas MC, Musher DM, Lahart C et al. Antibodies to capsular polysaccharides of Streptococcus pneumonioe after vaccination of human immunodeficiency virus-infected subjects with 23-valent pneumococcal vaccine. J Infect Dis 1992 ; 165:553-6.
33. Glaser JB, Volpe S, Aguirre A et al. Zidovudine improves response to pneumococcal vaccine among persons with AIDS and AIDS-related complex. J Infect Dis 1991 ; 164:761-4.
34. Janoff EN, Swindells S, Brichacek B, Stevenson M. Increased HIV-1 burden with immune activation following immunization with pneumococcal vaccine (Abstract). 35th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Illinois, 1995.
35. Hardy WD, Feinberg J, Finkelstein DM et al. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. N Engl J Med 1992 ; 327:1842-8.
36. Mayer HB, Rose DN, Cohen S et al. The effect of Pneumocystis carinii pneumonia prophylaxis regimens on the incidence of bacterial infections in HIV-infected patients. AIDS 1993 ; 7:1687-8.
37. Spector S, Gelber R, Mc Grath N et al. A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. N Engl J Med 1994 ; 331:1181-7.